Breaking News

LTS to Acquire Renaissance Lakewood

Expands capabilities in the CDMO space with specialization in nasal sprays and sterile dosage forms.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

LTS acquisition

LTS LOHMANN Therapie-Systeme AG, a pharmaceutical technology company is acquiring Renaissance Lakewood, LLC, a U.S.-based CDMO specializing in nasal sprays and sterile dosage forms. The transaction is expected to close before end of November 2025, subject to regulatory approvals. With the acquisition, Renaissance facilities will become part of LTS’ worldwide operations network, joining existing facilities in West Caldwell, NJ, St. Paul, MN, Andernach, Germany, and Netanya, Israel. The acqu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters